Glamour, Benita K.
Alaber, Omar
Cioffi, Gino
Chandar, Apoorva K.
Barnholtz-Sloan, Jill
Brock, Wendy
Falk, Gary W.
Canto, Marcia I.
Wang, Jean S.
Iyer, Prasad G.
Shaheen, Nicholas J.
Grady, William M.
Abrams, Julian A.
Thota, Prashanthi N.
Chak, Amitabh
Blum, Andrew E.
Funding for this research was provided by:
National Institutes of Health (U54CA163060, P50CA150964, P30DK09794, T35DK111373)
U.S. Department of Veterans Affairs (IK2CX001831)
Article History
Received: 13 November 2020
Accepted: 25 February 2021
First Online: 11 March 2021
Declarations
:
: WMG is on the advisory boards for Freenome, Guardant Health, and SEngine and consults for Diacarta. He is also an investigator for a clinical trial sponsored by Janssen and receives services for investigator initiated research from Tempus and Lucid Technologies. AC is a shareholder, consultants to and has a royalty interest in technology licensed to Lucid Diagnostics. AC has also consulted for Interpace Diagnostics.